Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients

References

• Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
   PubMed Web of Science ®Google Scholar
• Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20(4):102776. doi:10.1016/j.autrev.2021.102776
   PubMed Web of Science ®Google Scholar
• Albrecht K, Zink A. Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies. Arthritis Res Ther. 2017;19(1):68. doi:10.1186/s13075-017-1266-4
   PubMed Web of Science ®Google Scholar
• Feng X, Xu X, Shi Y, et al. Body mass index and the risk of rheumatoid arthritis: an updated dose-response meta-analysis. Biomed Res Int. 2019;2019:3579081. doi:10.1155/2019/3579081
   PubMed Web of Science ®Google Scholar
• Zhang Y, Johansson L, Andersson-Assarsson J, et al. Adiponectin associates with rheumatoid arthritis risk in overweight and obesity independently of other adipokines. J Clin Med. 2021;10(13):2791. doi:10.3390/jcm10132791
   PubMed Web of Science ®Google Scholar
• Targońska-Stepniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int. 2010;30(6):731–737. doi:10.1007/s00296-009-1053-x
   PubMed Web of Science ®Google Scholar
• Del Prete A, Salvi V, Sozzani S. Adipokines as potential biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014;2014:425068. doi:10.1155/2014/425068
   PubMed Web of Science ®Google Scholar
• Fatel ECS, Rosa FT, Anc S, Dichi I. Adipokines in rheumatoid arthritis. Adv Rheumatol. 2018;58:25. doi:10.1186/s42358-018-0026-8
   PubMedGoogle Scholar
• Khoramipour K, Chamari K, Hekmatikar AA, et al. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients. 2021;13(4):1180. doi:10.3390/nu13041180
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Prevoo ML, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–48. doi:10.1002/art.1780380107
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol. 2005;32(8):1432–1439.
   PubMed Web of Science ®Google Scholar
• Chihara K, Hattori N, Ichikawa N, Matsuda T, Saito T. Re-evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis. Sci Rep. 2020;10(1):15932. doi:10.1038/s41598-020-73068-2
   PubMed Web of Science ®Google Scholar
• Kamareddine L, Ghantous CM, Allouch S, et al. Between inflammation and autophagy: the role of leptin-adiponectin axis in cardiac remodeling. J Inflamm Res. 2021;14:5349–5365. doi:10.2147/JIR.S322231
   PubMed Web of Science ®Google Scholar
• Cici D, Corrado A, Rotondo C, et al. Adipokines and chronic rheumatic diseases: from inflammation to bone involvement. Clin Rev Bone Miner Metab. 2020;18:58–71. doi:10.1007/s12018-021-09275-w
   Web of Science ®Google Scholar
• Cao H, Lin J, Chen W, Xu G, Sun C. Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review. Autoimmunity. 2016;49(8):547–553. doi:10.1080/08916934.2016.1230847
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21(3):664–672. doi:10.1111/1756-185X
   PubMed Web of Science ®Google Scholar
• Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50(4):269–275. doi:10.2169/internalmedicine.50.4306
   PubMed Web of Science ®Google Scholar
• Carrión M, Frommer KW, Pérez-García S, Müller-Ladner U, Gomariz RP, Neumann E. The adipokine network in rheumatic joint diseases. Int J Mol Sci. 2019;20(17):4091. doi:10.3390/ijms20174091
   PubMed Web of Science ®Google Scholar
• Tian G, Liang JN, Wang ZY, Zhou D. Emerging role of leptin in rheumatoid arthritis. Clin Exp Immunol. 2014;177(3):557–570. doi:10.1111/cei.12372
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC. Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. Z Rheumatol. 2016;75(10):1021–1027. doi:10.1007/s00393-016-0050-1
   PubMed Web of Science ®Google Scholar
• Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64(8):1195–1198. doi:10.1136/ard.2004.032243
   PubMed Web of Science ®Google Scholar
• Oner SY, Volkan O, Oner C, Mengi A, Direskeneli H, Tasan DA. Serum leptin levels do not correlate with disease activity in rheumatoid arthritis. Acta Reumatol Port. 2015;40(1):50–54.
   PubMed Web of Science ®Google Scholar
• Batún-Garrido JAJ, Salas-Magaña M, Juárez-Rojop IE. Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis. Clin Rheumatol. 2018;37(3):631–637. doi:10.1007/s10067-017-3897-x
   PubMed Web of Science ®Google Scholar
• Shankar A, Syamala S, Xiao J, Muntner P. Relationship between plasma leptin level and chronic kidney disease. Int J Nephrol. 2012;2012:269532. doi:10.1155/2012/269532
   PubMedGoogle Scholar
• Lim CC, Teo BW, Tai ES, et al. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PLoS One. 2015;10(3):e0122009. doi:10.1371/journal.pone.0122009
   PubMed Web of Science ®Google Scholar
• Mao S, Fang L, Liu F, Jiang S, Wu L, Zhang J. Leptin and chronic kidney diseases. J Recept Signal Transduct Res. 2018;38(2):89–94. doi:10.1080/10799893.2018.1431278
   PubMed Web of Science ®Google Scholar
• É T, Mourot L, Dehecq B, Wendling D, É G, Dumoulin G. TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study. Eur J Nutr. 2014;53(3):951–961. doi:10.1007/s00394-013-0599-2
   PubMed Web of Science ®Google Scholar
• Marouen S, Barnetche T, Combe B, Morel J, Daïen CI. TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysis. Clin Exp Rheumatol. 2017;35(2):337–343.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Marotte H, Mulleman D, et al. Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study. Arthritis Res Ther. 2020;22(1):224. doi:10.1186/s13075-020-02297-7
   PubMed Web of Science ®Google Scholar